Introduction
Apoptosis is a cellular suicide functionally opposite to mitosis. It may play an important role in tissue growth control and removal of damaged and premalignant cells. The caspase family of aspartate-speci®c cysteine proteases has been demonstrated to be critical mediators in the cell death pathway (Nicholson and Villa et al., 1997) . Among the members of the caspase family, caspase-3/CPP32/ Yama/Apopain is a common and important eector of the apoptotic process. Caspase-3 preferentially cleaved the substrate proteins at the tetrapeptide sites with characteristic DXXD motif (Talanian et al., 1997; Thornberry et al., 1997) . A number of caspase-3 substrates has now been identi®ed, including protein kinases, the retinoblastoma protein, cytoskeletal proteins, and DNA fragmentation inducing proteins (Nicholson and Villa et al., 1997) . Cleavage of these substrates may either activate or inactivate their essential functions or produce the cleavage products with altered activities. p21
Waf1/Cip1 (p21) was originally identi®ed as an inhibitor of cyclin-dependent kinases (CDKs) (Gu et al., 1993; Harper et al., 1993; Xiong et al., 1993) . It was also a transcriptional target of the tumor suppressor gene p53, and its expression is strongly induced by DNA damage in cells expressing functional p53 (El-Deiry et al., 1993; Dulic et al., 1994; El-Deiry et al., 1994) . p21 could eciently block cell cycle progression through inhibition of a broader spectrum of CDKs required for G 1 /S transition by stoichiometric binding Morgan, 1995) . In addition, p21 can also bind the proliferating cell nuclear antigen (PCNA) (Flores-Rozas et al., 1994) leading to an inhibition of DNA replication but not DNA repair in vitro (Li et al., 1994) . In DNA damaged cells, p53 was involved in G 1 arrest and apoptosis, while p21 was only required for p53-dependent G 1 arrest but not for apoptosis (Deng et al., 1995; Waldman et al., 1995) . Moreover, p21 has recently been implicated in protecting cells from apoptosis initiated by stress or p53 induction, although the mechanisms remain obscure (Polyak et al., 1996; Gorospe et al., 1997) .
Because several cell cycle-regulating cyclins and CDKs are activated inappropriately during apoptosis (Shi et al., 1994; Fotedar et al., 1995; Shimizu et al., 1995; Meikrantz and Schlegel, 1996) , we examined the participation and regulation of p21 in the apoptotic process of cancer cells induced by DNA-damaging agents. We discovered that p21
Waf1/Cip1 was cleaved during apoptosis in cancer cells. We demonstrated that the activated caspase-3 was responsible for the p21 cleavage at the site of DHVD 112; L. Recently, the cleavage of p21 by caspase-3-like proteases was also observed in endothelial cell apoptosis (Levkau et al., 1998) . Compared with the wild-type p21, the cleaved p21 fragment could no more arrest the cells in G 1 phase nor suppress the cells undergoing apoptosis. Our ®ndings indicate that the cleavage-mediated inactivation of p21 is a critical step in the acceleration of chemotherapy-induced apoptotic cell death in cancer cells.
Results
Cleavage of p21 while the cells released from G 1 arrest and undergoing apoptosis To examine whether cell cycle control proteins were involved in DNA damage-induced apoptosis, human lung carcinoma A549 cells expressing functional wildtype p53 (Lehman et al., 1991) were used and treated with the DNA-damaging agent camptothecin (CPT). After 24 h incubation with CPT, 61% of the cells were arrested in G 1 phase (Figure 1a , middle panel), while 48 h incubation with CPT reduced the number of G 1 -arrested A549 cells to 31% and increased the number of apoptotic cells (as appeared in sub-G 1 population) to 49% (Figure 1a , right panel). Apoptosis with nuclear fragmentation was observed only in the cells that had been treated with CPT for 48 h, suggesting that apoptosis occurred after the cells exiting G 1 phase (Figure 1a right panel) . The expression of p53 was induced and sustained throughout the 48 h treatment with CPT ( Figure 1b) . Unlike p53, p21 protein was basally expressed in untreated cells and was strongly induced by treating the cells with CPT for 24 h. When the cells were incubated for 48 h, the expression of p21 dramatically decreased despite the high level expression of p53 (Figure 1b) . In contrast, we found a novel band at approximately 15 kDa in the apoptotic A549 cell lysates (Figure 1b) . This novel band might be a cleaved fragment of p21 because it was cross-reactive to the anti-p21 speci®c monoclonal antibody. Likewise, the 15 kDa fragment was also observed when A549 cells were treated with other DNA-damaging agents, cisplatin (cDDP) and adriamycin (ADM) (Figure 1c) . Similar results were also obtained in human cervical carcinoma HeLa and human ®brosarcoma HT1080 cells treated with CPT ( Figure 1d ). However, the correlated changes in the expression level of other cell cycle components, such as cyclins and CDKs, were not observed whether A549 cells underwent apoptosis or not (data not shown). Thus, the appearance of cleaved p21 fragment was a generally observed phenomena during apoptosis in the cells treated with DNAdamaging agents.
Involvement of caspase-3 in the p21 cleavage
As caspases are activated and involved in many types of apoptotic cell death (Nicholson and Villa et al., 1997) , we next assessed whether the 15 kDa fragment was derived from cleavage of p21 by caspase-like proteases. As shown in Figure 2a , the cell-permeable caspase inhibitor benzyloxycarbonylAsp -CH 2 OC (O) -2, 6 -dichlorobenzene (Z-Asp-CH 2 -DCB) (Mashima et al., 1997) suppressed CPTinduced apoptosis of A549 cells. Meanwhile, the appearance of the 15 kDa fragment of p21 was also blocked by the addition of Z-Asp-CH 2 -DCB to the cells (Figure 2b ), whereas the expression of either p53 or p21 induced by DNA damage was not aected (Figure 2b ). Other cell-permeable caspase inhibitors, Z-Val-Ala-Asp-CH 2 -DCB (Z-VAD-CH 2 -DCB) and ZGlu-Val-Asp-CH 2 -DCB (Z-EVD-CH 2 -DCB), also prevent the appearance of the 15 kDa fragment of p21 (data not shown). These results indicate that caspases may be involved in the proteolytic cleavage of p21 and execution of DNA damage-induced apoptosis in A549 cells.
Further experiments using 35 S-labeled in vitro transcribed and translated p21 showed that it was cleaved when incubated with CPT-treated nuclear extracts of A549 cells in vitro (Figure 2c ), con®rming that p21 was speci®cally cleaved during apoptotic cell death. This cleavage was speci®cally inhibited by adding of a tetrapeptide inhibitor to caspase-3 (acetyl-DEVD aldehyde; DEVD-CHO) but not by adding the same kind of inhibitor to caspase-1 (acetyl-YVAD aldehyde; YVAD-CHO) or aprotinin under the same conditions (Figure 2c ). The p21 cleavage was partially inhibited by adding a cowpox virus serpin CrmA protein (Figure 2c ). Alternatively, a caspase-3-immunodepleted CPT-treated nuclear ex-
Waf1/Cip1 is cleaved to produce a 15 kDa fragment while cells were exiting G 1 phase and undergoing apoptosis. (a) A549 cells were incubated with 10 mg/ml of CPT for 0, 24 and 48 h. The percentage of the G 1 , S, G 2 /M and sub-G 1 (less than G 1 ) population was determined by propidium iodide staining and FACScan¯ow cytometry. The apoptotic nuclear fragmentation was evaluated by DAPI staining. (b) A549 cells were cultured with or without 10 mg/ml of CPT for the indicated time. The whole cell lysates were electrophoresed on a 15 ± 25% gradient SDS-polyacrylamide gel and were immunoblotted with anti-p21 monoclonal antibody and anti-p53 monoclonal antibody. Molecular size markers are indicated (in kilodaltons). (c) A549 cells were treated with medium alone (Control), 10 mg/ml of cDDP, or 3 mM of ADM for 48 h. Then, the cell lysates were immunoblotted with anti-p21 monoclonal antibody. (d) A549, HeLa and HT1080 cells were treated with or without 10 mg/ml of CPT for 48 h. Then, the cell lysates were immunoblotted with anti-p21 monoclonal antibody tracts of A549 cells had no eect on p21 cleavage (data not shown). Thus, active caspase-3, which is present in the apoptotic nuclear extracts of A549 cells, is responsible for the direct cleavage of p21. This was further supported by the fact that p21 was cleaved when recombinant caspase-3 was used ( Figure 2d ).
Among the dierent caspase-family members, caspase-3 was known to cleave the substrates that contain Asp residues at the P1 and P4 positions (P4 to P1; DXXD in which X may be any amino acid) (Talanian et al., 1997; Thornberry et al., 1997) . As we noted, p21 contains a DHVD sequence that is localized at amino acid residues 109 ± 112. To assess whether this sequence could indeed function as a caspase-3 cleavage site, we constructed several p21 mutants in which the Asp residue was converted to Ala. (Levkau et al., 1998) . The cleaved p21 fragment, showing an approximately 6 kDa mobility reduction, as compared with that of full length p21, resulted from the removal of C-terminal 52 amino acids of p21.
The biological activities of cleaved p21 fragment in regulating cell cycle and apoptosis
To determine the biological functions of the cleaved p21 fragment, we transfected FLAG-tagged cleaved p21 fragment (p21DC) and FLAG-tagged wild-type p21 (p21WT) into human embryonic kidney 293T cells (Figure 3a) . Consistent with previous reports (Brugarolas et al., 1995; Deng et al., 1995; Waldman et al., 1995) , expression of p21WT arrested the cells in G 1 phase; however, the expression of p21DC did not (Figure 3b ), indicating that the cleaved p21 fragment lost its function and allowed the cells to exit G 1 phase. When the transfected cells were further treated with etoposide, we observed that the expression of p21WT much suppressed the formation of the sub-G 1 population (apoptotic cells) as well as the activation of caspase-3-like proteases. In contrast, the expression of p21DC had no such eects (Figure 3c and d). On the other hand, the expression of p21DC appeared not to augment the apoptotic potential as compared with mock transfection (Figure 3c and d) . Furthermore, overexpression of the cleavage-resistant mutant of p21 (D112A), in which the caspase-3 recognition site Asp 112 was converted to Ala (Figure 2e ), was more eective than the wild-type p21 on suppressing the activation of caspase-3-like proteases (data not shown), indicating that the cleavage of p21 may be directly involved in the execution of apoptosis. Therefore, expression of wild-
Waf1/Cip1 is cleaved between Asp 112 and Leu 113 by caspase-3. (a and b) A549 cells were incubated with medium alone, 10 mg/ml of CPT, or 10 mg/ml of CPT in the presence of 100 mg/ml of Z-Asp-CH 2 -DCB (Z-Asp). The percentage of the sub-G 1 population of A549 cells was determined by propidium iodide staining and FACScan¯ow cytometry (a). A549 cell lysates were immunoblotted with anti-p21 monoclonal antibody and anti-p53 monoclonal antibody (b) . (c) 35 S-labeled Xpress-tagged p21 was prepared and incubated with the apoptotic A549 nuclear extracts (10 mg) for 90 min at 308C with or without 100 nM of YVAD-CHO, 100 nM of DEVD-CHO, 2 mg/ml of aprotinin, or 2.5 nM of CrmA protein. The reactions were then applied onto a 15 ± 25% gradient SDS-polyacrylamide gel, followed by autoradiography. (d) 35 S-labeled Xpress-tagged p21 was incubated with the indicated amounts of agarose-conjugated recombinant caspase-3 for 90 min at 308C. The reactions were then applied onto a 15 ± 25% gradient SDS-polyacrylamide gel, followed by autoradiography. (e) 35 S-labeled Xpress-tagged wild-type and indicated mutant p21 proteins were incubated with agarose-conjugated recombinant caspase-3 for 90 min at 308C. The reactions were then applied onto a 15 ± 25% gradient SDS-polyacrylamide gel, followed by autoradiography type p21, but not the cleaved p21 fragment, directs cells to arrest in G 1 phase and protects them from undergoing apoptosis induced by DNA damage.
Failure of the cleaved p21 fragment to bind to PCNA and to localize in the nucleus Since p21 functions through its inhibitory eect on CDKs and PCNA (Flores-Rozas et al., 1994; Li et al., 1994; Morgan, 1995) , we next investigated the associations of the cleaved p21 fragment with PCNA and CDK2. FLAG-tagged p21DC and FLAG-tagged p21WT were transfected into 293T cells and immunoprecipitated from total cell lysates by anti-FLAG antibody to determine the level of PCNA and CDK2 associated with p21DC and p21WT, respectively. Consistent with previous reports that the C-terminus of p21 was required for its interaction with the PCNA (Chen et al., 1995; Nakanishi et al., 1995b) , we found that deletion of the C-terminal 52 amino acid (p21DC) completely prevented its binding to PCNA (Figure 4a ).
As the N-terminus of p21 was responsible for the binding to the CDK2 (Chen et al., 1995; Nakanishi et al., 1995a) , both p21DC and p21WT could bind to the CDK2 (Figure 4a) . However, the in vitro histone H1 kinase assay revealed that p21DC was less eective than p21WT on inhibiting the CDK2 activity (data not shown).
To investigate why the function of p21 was impaired in vivo after the cleavage, we further examined the intracellular localization of p21DC because the Cterminal domain clipped o from p21 contains a nuclear localization sequence (El-Deiry et al., 1993; Harper et al., 1993 ). An immunostaining experiment using an antibody to the FLAG epitope showed that p21WT localized exclusively in the nucleus of the 293T and A549 cells that had been transfected with FLAGtagged p21WT (Figure 4b, left panel) . However, p21DC was detected mostly in the cytoplasm of the cells that had been transfected with FLAG-tagged p21DC (Figure 4b, right panel) . Likewise, 48 h after treatment of A549 cells with CPT, double staining using DAPI and an antibody to N-terminus of p21 showed that the endogenous p21 was substantially decreased in the nucleus and the immunoreactive cleaved p21 was also observed in the cytoplasm of apoptotic cells (Figure 4c , right panels). However, the intact p21 with a strong immunoreactivity was localized in the nucleus of the survival cells (Figure 4c, left panel) . When examined the intracellular localization of PCNA and CDK2, we found that they were primarily localized in the nucleus whether A549 cells underwent apoptosis or not (data not shown). Thus, our present studies suggest that caspase-3-induced inactivation of p21 might be mediated by removal of the C-terminal domain of p21, which is essential for its interaction with the PCNA and the nuclear localization.
Discussion
Identi®cation of the key substrates cleaved by caspases is important to understand the molecular mechanisms critical for apoptosis induction (Martin and Green, 1995) . We showed that p21 was speci®cally cleaved to produce a 15 kDa fragment during DNA damageinduced apoptosis (Figure 1b) . The cleavage of p21 might be of general signi®cance because it was induced by diverse DNA damaging agents in dierent cancer cell lines (Figure 1c and d) . The fact that both apoptosis (Figure 2a ) and p21 cleavage (Figure 2b) could be inhibited by a cell permeable caspase inhibitor Z-Asp-CH 2 -DCB (Mashima et al., 1995) indicated that caspases were involved in the proteolytic cleavage of p21. Four lines of evidence support the assumption that caspase-3 was responsible for the p21 cleavage in apoptotic A549 cells. First, a speci®c tetrapeptide inhibitor of caspase-3, DEVD-CHO, could eciently block the p21 cleavage in vitro ( Figure 2c) ; second, mutation of the putative cleavage site (   109   DHVD   112 ), which contained Asp at the P1 and P4 positions that were preferentially recognized by caspase-3 (Talanian et al., 1997; Thornberry et al., 1997) , prevented p21 from being cleaved ( Figure 2e) ; third, the immunodepletion of caspase-3 from apoptotic A549 lysates eliminated the p21 cleavage (data not shown); fourth, recombinant active caspase-3 cleaved the in vitro Waf1/Cip1 fragment failed to eciently mediate G 1 arrest or to suppress apoptosis. 293T cells were transfected with equal amounts of pFLAG-CMV-2 vectors containing empty (Mock), wild-type p21 cDNA (FLAGp21WT), or C-terminal truncated form of p21 cDNA (FLAGp21DC). (a) After transfection for 24 h, the cell lysates were immunoblotted with anti-FLAG M5 monoclonal antibody. (b) The percentage of the G 1 population of the transfectants was determined by propidium iodide staining and FACScan¯ow cytometry. (c) Transfectants were recovered for 24 h and were treated with 60 mg/ml of etoposide for an additional 48 h. The percentage of the G 1 , S, G 2 /M and sub-G 1 populations was evaluated by propidium iodide staining and FACScan¯ow cytometry. (d) Transfectants were recovered for 24 h and were treated with 60 mg/ml of etoposide for an additional 48 h. The DEVDase activity in the cells was determined using a¯uorogenic-labeled tetrapeptide (DEVD-AMC). The value of DEVDase activity in the untreated, mock transfectants was normalized as 100% translated p21 in a dose-dependent manner (Figure 2d ). However, we can not rule out the possibility that other caspase is also involved in p21 cleavage. Indeed, Levkau recently reported that caspase-7 but not caspase-6 has the same ability as caspase-3 to cleave endogenous p21 (Levkau et al., 1998) . p21 acted as an important cell cycle regulator through two discrete functional domains. N-terminal residues 10 ± 80 were identi®ed as the cyclin and CDKbinding region (Chen et al., 1995) . C-terminal residues 133 ± 164 were reported to act as the PCNA-binding region (Chen et al., 1995; Luo et al., 1995; Nakanishi et al., 1995a) . Cleavage of p21 during apoptosis resulted in loss of the 52 amino acids at the C-terminus, which include the nuclear localization signal (residues 140 ± 156), the PCNA binding region and a recently identi®ed second cyclin-binding site (Adams et al., 1996; Chen et al., 1996; Ball et al., 1997) . Consistent with these observations, we found FLAG-p21DC, a fusion protein lacking the 52 amino acids at the Cterminus, was no longer able to bind to PCNA whereas the binding to CDK2 in vitro was not aected ( Figure  4a ). However, under in vivo physiological conditions, p21DC was less eective in inhibiting the cell cycle and apoptosis than was wild-type p21 (Figure 3 ). This could be due to the lack of the second cyclin-binding site and the dierent intracellular localization of p21DC, compared with the wild-type p21. Indeed, immuno¯uorescence staining showed that overexpressed wild-type p21 was restricted to the nucleus whereas the p21DC was generally localized to the cytoplasm (Figure 4b ). Since CDK2 remain restricted to localize in the nucleus (data not shown), the interaction between p21DC and CDK2 observed in Figure 4a could be an artifact of immunoprecipitation due to the use of total cell lysates in which both cytoplasmic and nuclear extracts were mixed together. Thus, the p21DC in the cytoplasm could bind in vitro to the CDK2 from the nuclear extracts. Moreover, the amount of endogenous p21 was decreased in the nucleus of apoptotic A549 cells, and the cleaved p21 fragment appeared in the cytoplasm (Figure 4c ). This observation and the fact that active caspase-3 exists in the nuclear extracts of apoptotic A549 cells suggest that p21 cleavage occurs in the nucleus, and the cleaved fragment may exit the nucleus into cytoplasm. Thus, the lack of the putative nuclear localization sequence and PCNA binding domain in cleaved p21 Figure 4 The cleaved p21 fragment lacked the abilities to bind to the PCNA and to localize in the nucleus. (a) 293T cells were transfected with equal amounts of pFLAG-CMV-2 vectors containing empty (Mock), wild-type p21 cDNA (FLAG-p21WT), or Cterminal truncated form of p21 cDNA (FLAG-p21DC). The FLAG-tagged p21WT and p21DC proteins were immunoprecipitated using agarose-conjugated anti-FLAG M2 monoclonal antibody and then immunoblotted with anti-PCNA monoclonal antibody (upper panel) or anti-CDK2 polyclonal antibody (lower panel). (b) 293T (upper panel) or A549 (lower panel) cells were transfected with equal amounts of pFLAG-CMV-2 vectors containing wild-type p21 cDNA (FLAG-p21WT) or C-terminal truncated form of p21 cDNA (FLAG-p21DC). The expressed FLAG-tagged p21WT and p21DC proteins were visualized by immuno¯uorescence staining with anti-FLAG M5 monoclonal antibody. (c) A549 cells were treated with 10 mg/ml of CPT for 48 h and were stained with DAPI (upper panel) and anti-p21 monoclonal antibody (lower panel) fragment might explain why it was not restricted to the nucleus. Reduction of the total amounts of wild-type p21 and the loss of function of the cleaved p21 fragment in apoptotic cells might lead to the inactivation of p21 as a nuclear protein to bind and to inhibit PCNA and cyclin-CDKs, which in turn resulted in deregulation of cell cycle and increase in the sensitivity of the cells to apoptosis-inducing stimuli.
Recent observations suggested that p21 was also implicated in the survival response to apoptosis. Overexpression of p21 blocked apoptosis during myogenic dierentiation (Wang and Walsh, 1996) . In contrast, the absence of p21 not only abrogated the cell cycle blocks but also resulted in the subsequent apoptosis in the p21 7/7 cells (Polyak et al., 1996; Gorospe et al., 1997) . Furthermore, the antisense oligonucleotides to p21 promoted apoptotic cell death (Gorospe and Holbrook, 1996; Poluha et al., 1996) . Our present results also support p21 as a general apoptosis-inhibitory protein because overexpression of wild-type p21 suppressed etoposide-induced apoptosis in 293T cells (Figure 3c) . Moreover, the overexpression of a cleavage-resistant mutant p21 (D112A) protein, which could not be recognized by caspase-3, suppressed the caspase activity even more eectively than did the wild-type p21 (data not shown). This observation could rule out the possibility that the p21 suppress apoptosis as a competitive inhibitor of caspases, like as the baculovirus p35 protein and cowpox virus serpin CrmA protein (Komiyama et al., 1994; Xue and Horvitz, 1995) . Although cleavage of p21 is a downsteam event of caspase activation, p21 inhibit apoptosis probably at upstream of caspase through arresting the cells in G1 phase after DNA damage (King and Cidlowski, 1995; Meikrantz and Schlegel, 1995) . p21 might also inhibit apoptosis through its ability to bind PCNA to inhibit the DNA replication but not to inhibit the nucleotide-excision repair, an intrinsic cellular response to damageresponsive DNA repair synthesis (Li et al., 1994) . Thus, the non-cleavable p21 had the stronger ability to inhibit further promotion of apoptotic process than wild-type p21.
Because the eect of transfection of p21DC on apoptosis was comparable to that of mock transfection (Figure 3c ), the cleaved p21 fragment (p21DC) might not promote apoptosis by itself. However, we could not rule out the possibility that the C-terminal p21 fragment could aect apoptosis progression by interacting with PCNA or other unidenti®ed proteins. Actually, we could not detect the immunoreactive Cterminal form of p21 using the speci®c antibody to Cterminus of p21 (data not shown), which indicated to us that the C-terminal fragment might degrade or processed quickly after caspase-3-mediated cleavage.
The tumor suppressor p53 was a cell cycle checkpoint protein that contributed to preserving genetic stability by mediating either a G 1 arrest or apoptosis after DNA damage. However, the biochemical and genetic determinants that controlled which pathways ± arrest or apoptosis ± would be followed by a particular cell after p53 induction remain cloudy (Polyak et al., 1997) . p21 was involved in p53-mediated G 1 arrest through binding to and inactivating the CDKs and the PCNA (Waldman et al., 1995) . Our present ®ndings suggest that caspase-3 is one of the determinants of p53-mediated apoptosis because it overcomes the p21-mediated G 1 arrest and apoptosis suppression. When p21 was cleaved and inactivated by caspase-3, G 1 arrested cells would be converted from growth arrest to apoptosis. Inhibiting caspase-3 with ZAsp-CH 2 -DCB also resulted in G 1 arrest and cell survival, despite accumulation of p53 (Figure 2a) . Thus, activation of caspase-3 determines that cells will undergo p53-mediated apoptosis instead of arresting in G 1 phase. However, the mechanisms of caspase-3 activation by p53 were largely unknown. One candidate is the death-promoter Bax protein because it can be activated directly by p53 and is involved in apoptosis promotion (Miyashita and Reed, 1995) . Bax has the ability to form heterodimers with deathsuppressor Bcl-2 and Bcl-X L proteins (Oltvai et al., 1993) and neutralize their functions to facilitate caspase activation (Kluck et al., 1997; Yang et al., 1997; Rosse et al., 1998) . In addition, p53-mediated transcriptional induction of redox-related genes and formation of reactive oxygen species might also be involved in the activation of caspases (Polyak et al., 1997) .
Our results provide considerable information to aid in developing chemotherapeutic approaches for cancer. Because caspase-3 overcomes the apoptosis-inhibiting function of p21, therapies aimed at activating caspase-3 could prove most successful for rendering growtharrested cancer cells vulnerable to apoptosis.
Materials and methods

Cell culture and drug treatment
Human lung cancer A549 cells were cultured in RPMI 1640 medium supplemented with 10% fetal bovine serum (FBS). Human cervical carcinoma HeLa cells, human sarcoma HT1080 cells, and human embryonic kidney 293T cells were cultured in Dulbecco's modi®ed Eagle's medium supplied with 10% FBS. These cells were treated with or without CPT (generous gifts from Yakult, Tokyo, Japan), cDDP (kindly provided by Bristol Meyers-Squibb, Tokyo, Japan), ADM (generous gifts from Kyowa Hakko Kogyo Co., Ltd., Tokyo, Japan), etoposide (kindly provided by Bristol Meyers-Squibb), and Z-Asp-CH 2 -DCB (Funakoshi, Tokyo, Japan).
Plasmid constructions and in vitro mutagenesis
The human p21 cDNA was generated by RT ± PCR using mRNA isolated from A549 cells as the template. The sense and antisense primers for human p21 were 5'-GCAC-CATCTCAGAACCGGCTG-3' and 5'-GATTAGGGCT-TCCTCTTGGAGAAG-3', respectively. The C-terminal truncated form of p21 cDNA (p21DC; amino acids 1 ± 112) was generated by RT ± PCR using the sense (5'-GCACCATCTCAGAACCGGCTG-3') and antisense (5'-GACTAGTCCACATGGTCTTCCTC-3') primers. The PCR products were cloned into a pCRII vector (Invitrogen, San Diego, CA, USA). Substitutions of aspartic acid at 87, 109, 112 and 136 with alanine (D87A, D109A, D112A and D136A, respectively) in p21 cDNA were accomplished by converting the aspartic acid codon GAT or GAC to alanine codon GCT or GCC by PCR mutagenesis using the QuickChange site-directed mutagenesis kit (Stratagene, La Jolla, CA, USA). All these cDNAs were used as templates in a double-stranded sequenase reaction before subcloning (Amersham, Cleveland, Ohio, USA), using SP6 and T7 promoters as primers. After restriction with EcoRI, these cDNAs were subcloned into an EcoRI site of the pcDNA3 vector (Invitrogen) in which the sequence between BamHI and EcoRI sites had been replaced with Xpress epitope (DLYDDDDK) containing the translation initiation codon ATG at the 5' end (Fujita et al., 1998) or an EcoRI site of the pFLAG-CMV-2 vector (Kodak, New Haven, CT, USA).
Transfections
Ten mg of the pFLAG-CMV-2 vectors containing empty, wild-type p21 and p21DC cDNAs were transiently transfected into A549 and 293T cells using a Superfect Transfection Reagent according to the manufacturer's instruction (Qiagen, Hilden, Germany). We typically transfected between 50 ± 70% of cells as judged using a control pcDNA3 vector expressing EGFP protein. In some experiments, the transfected 293T cells were treated with 60 mg/ml of etoposide for an additional 48 h to induce apoptosis.
Cell cycle and apoptosis analyses
The¯ow cytometric analysis of cell cycle and cell viability was performed according to the previously described method (Tomida et al., 1996) . Brie¯y, 1610 6 cells were harvested and ®xed with 70% ethanol followed by treatment with 1 mg/ml RNase. The cells were stained with PI solution (3.2 mM sodium citrate, 50 mg/ml propidium iodide, and 0.1% Triton-X100) for 30 min at 238C. Then the cells were resuspended and analysed using a Becton Dickinson FACScan¯ow cytometer (Barintree, MA, USA). The percentages of G 1 , S, G 2 /M and sub-G 1 (apoptotic cells) populations were calculated, respectively. Morphological examination of apoptosis was examined by staining the nuclei of the cells with DAPI, as described previously (Lee et al., 1996) .
p21 cleavage assay
The wild-type and mutant p21 proteins were produced by in vitro transcription-translation and labeled with 35 Smethionine using a rabbit reticulocyte lysate system (Promega, Madison, WI, USA). Each of 35 S-labeled p21 and the mutants (2 ml) was incubated with the apoptotic A549 nuclear extracts (10 mg) or agarose-conjugated recombinant caspase-3 (Upstate Biotechnology, Lake Placid, NY, USA) in caspase assay buer [20 mM HEPES (pH 7.4), 10% glycerol and 2 mM dithiothreitol] for 90 min at 308C. In some experiments, a tetrapeptide inhibitor of caspase-1 (YVAD-CHO; Peptide Institute, Osaka, Japan), a tetrapeptide inhibitor of caspase-3 (DEVD-CHO; Peptide Institute), aprotinin (Sigma, St Louis, MO, USA), or CrmA Protein (Kamiya Biomedical Company, Seattle, WA, USA) were added to the reactions. The reactions were applied to a 15 ± 25% gradient polyacrylamide gel, followed by autoradiography.
Measurement of DEVDase activity
Cells were harvested and lysed in lysis buer containing 10 mM HEPES (pH 7.4), 2 mM EDTA, 0.1% CHAPS and 5 mM dithiothreitol. The cell lysates were obtained by centrifugation at 48C for 30 min at 40 000 r.p.m. 20 mg of the cell lysate was used to incubate with 20 mM of thē uorogenic substrate DEVD-7-amino-4-methylcoumarin (DEVD-AMC; Peptide Institute) in caspase assay buer for 1 h at 378C. The AMC released from the¯uorogenic substrates was excited at 380 nm and the emission was measured at 460 nm using a Hitachi¯uorescence spectrophotometer, model F-2000 (Hitachi, Tokyo, Japan).
Western blot analysis and immunoprecipitation
Western blot analysis was performed as described previously (Tomida et al., 1996) . The antibodies used were as follows: anti-p53 monoclonal antibody (Calbiochem, La Jolla, CA, USA), anti-p21 monoclonal antibody (Transduction Laboratories, Lexington, KY, USA), anti-PCNA monoclonal antibody (Upstate Biotechnology), anti-CDK2 polyclonal antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and anti-FLAG M5 monoclonal antibody (Kodak). The FLAG-tagged proteins were immunoprecipitated using an agarose-conjugated anti-FLAG M2 monoclonal antibody (Kodak).
Immuno¯uorescence staining
Cells were ®xed with 3.7% formaldehyde in PBS for 20 min and then blocked and permeabilized with 10% FBS in PBS/0.1% Triton X100 for 30 min at 238C. For detection of p21 and p21DC proteins, the anti-FLAG M5 monoclonal antibody or the anti-p21 monoclonal antibody was used as the primary antibody. Then the cells were treated with a¯uorescein isothiocyanate (FITC)-labeled second antibody.
